about
Furin at the cutting edge: from protein traffic to embryogenesis and diseaseAnthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxinAnthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune responseAnthrax Toxins in Context of Bacillus anthracis Spores and Spore GerminationThe structural basis for substrate and inhibitor selectivity of the anthrax lethal factorCD4+ T Cells Targeting Dominant and Cryptic Epitopes from Bacillus anthracis Lethal FactorImaging specific cell surface protease activity in living cells using reengineered bacterial cytotoxinsApoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinaseNew developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.Suppression of dendritic cell activation by anthrax lethal toxin and edema toxin depends on multiple factors including cell source, stimulus used, and function testedControl of anthrax toxin gene expression by the transition state regulator abrB.Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathwaysConsequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.Hemodynamic effects of anthrax toxins in the rabbit model and the cardiac pathology induced by lethal toxin.The physiologic responses of Dutch belted rabbits infected with inhalational anthraxAnthrax vaccines: present status and future prospects.[Anthrax. The growing danger].Neutralization of B. anthracis toxins during ex vivo phagocytosis.Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.Glycoconjugates prevent B. anthracis toxin-induced cell death through binding while activating macrophages.Anthrax: what should the otolaryngologist know?Anthrax Lethal Toxin Inhibits the Production of Proinflammatory Cytokines
P2860
Q24670432-AD283CB6-E9A3-4D17-9897-D2A64978E8CAQ24796044-139A39D3-C709-410A-9EB8-F8878043C292Q24816298-C106C734-427B-43C2-B734-272ECB9B52CBQ26796601-3297EADD-E3C9-4D35-B1E9-1C36AE136C58Q27642935-93708BEF-EB71-4FFD-A0A4-6EAE642176BDQ28383022-9454275D-0763-42A7-A335-8960FAA6434CQ33432028-45E93677-5EC4-4A90-BB2A-390FAD1034F2Q34016286-1F354C65-90D5-4154-86C6-5CECA642144DQ34066161-BD2B7359-6814-4D3E-8B78-F4EE2380F306Q34364568-1B0E02FE-59B3-4EEA-A476-E44A5FE55A6CQ34435873-C92CDD16-1A8E-45BA-A268-3952FA81FF75Q35054868-B70A88E9-076F-4115-9963-B35F8CF3D7F2Q35155807-B90CE391-4B95-41C9-A34C-ECF8BF36258AQ35458938-A4C82F6B-50E3-47FE-866A-D3DA05A091B9Q37322409-E0F9027E-195C-4483-A9CD-380E55034CF3Q38132268-0E9F1530-64A8-4820-9AE2-8112831F2744Q44045048-E3345241-E6A3-45BE-9DEB-C7B8AEE398BDQ44518346-5EF3EBC8-C790-4D57-A3A9-03410C856631Q45219880-A671A0F1-3F7C-45FC-A3F4-E0B4737C8B8FQ50264189-DC8D4268-4659-41D2-B4DD-2A1927C60DD5Q51699470-23BB4130-8E12-42C5-9C45-4FA849FCAF8BQ58919748-DBB32FC1-33F9-4162-AEB0-7577EECD406F
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Anthrax toxins.
@ast
Anthrax toxins.
@en
type
label
Anthrax toxins.
@ast
Anthrax toxins.
@en
prefLabel
Anthrax toxins.
@ast
Anthrax toxins.
@en
P356
P1476
Anthrax toxins
@en
P2093
Vande Woude GF
P2888
P304
P356
10.1007/S000180050399
P407
P577
1999-09-01T00:00:00Z